See more : Inventus Mining Corp. (GNGXF) Income Statement Analysis – Financial Results
Complete financial analysis of NeueHealth, Inc. (NEUE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NeueHealth, Inc., a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- Aris Mining Corporation (TPRFF) Income Statement Analysis – Financial Results
- KOC METALURJI (KOCMT.IS) Income Statement Analysis – Financial Results
- Glass Houses Acquisition Corp. (GLHA) Income Statement Analysis – Financial Results
- Suga International Holdings Limited (0912.HK) Income Statement Analysis – Financial Results
- Kingston Financial Group Limited (1031.HK) Income Statement Analysis – Financial Results
NeueHealth, Inc. (NEUE)
About NeueHealth, Inc.
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.16B | 751.16M | 1.51B | 514.89M | 280.67M | 130.63M |
| Cost of Revenue | 996.58M | 662.97M | 1.29B | 451.92M | 0.00 | 0.00 |
| Gross Profit | 164.22M | 88.19M | 218.88M | 62.97M | 280.67M | 130.63M |
| Gross Profit Ratio | 14.15% | 11.74% | 14.47% | 12.23% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 19.43M | 0.00 | 0.00 |
| General & Administrative | 259.16M | 315.11M | 388.55M | 168.97M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 82.34M | 76.92M | 34.56M | 0.00 | 0.00 |
| SG&A | 259.16M | 315.11M | 465.48M | 203.53M | 180.49M | 95.84M |
| Other Expenses | 482.06M | 784.00K | 1.23M | -413.12M | -181.02M | -96.87M |
| Operating Expenses | 741.22M | 385.16M | 562.50M | 233.35M | 181.02M | 96.87M |
| Cost & Expenses | 1.75B | 1.05B | 1.86B | 685.27M | -405.41M | -193.27M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 38.20M | 12.82M | 7.23M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 18.30M | 30.71M | 35.05M | 8.29M | 1.13M | 1.03M |
| EBITDA | -566.80M | -246.39M | -308.58M | -249.31M | -124.20M | -61.61M |
| EBITDA Ratio | -48.83% | -32.80% | -20.28% | -31.48% | 0.40% | 0.79% |
| Operating Income | -577.00M | -368.76M | -343.63M | -170.38M | -125.34M | -62.64M |
| Operating Income Ratio | -49.71% | -49.09% | -22.71% | -33.09% | -44.66% | -47.95% |
| Total Other Income/Expenses | -52.17M | -84.61M | -6.00M | -3.80M | 0.00 | 0.00 |
| Income Before Tax | -629.17M | -381.58M | -349.63M | -170.38M | -125.34M | -62.64M |
| Income Before Tax Ratio | -54.20% | -50.80% | -23.11% | -33.09% | -44.66% | -47.95% |
| Income Tax Expense | -1.43M | 3.66M | -26.52M | -9.16M | 0.00 | 0.00 |
| Net Income | -1.15B | -1.46B | -1.18B | -248.44M | -125.34M | -62.64M |
| Net Income Ratio | -99.19% | -193.77% | -78.31% | -48.25% | -44.66% | -47.95% |
| EPS | -150.94 | -185.00 | -241.66 | -32.30 | -16.03 | -8.01 |
| EPS Diluted | -150.94 | -185.00 | -241.66 | -32.30 | -16.03 | -8.01 |
| Weighted Avg Shares Out | 7.95M | 7.87M | 4.90M | 7.69M | 7.82M | 7.82M |
| Weighted Avg Shares Out (Dil) | 7.95M | 7.87M | 4.90M | 7.69M | 7.82M | 7.82M |
NeueHealth to Host First Quarter 2024 Earnings Conference Call on May 8, 2024
NeueHealth Enters into Amendment to its Credit Facility
NeueHealth, Inc. (NEUE) Q4 2023 Earnings Call Transcript
NeueHealth Reports Fourth Quarter and Full Year 2023 Results
Source: https://incomestatements.info
Category: Stock Reports